VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > GEHC has not objected to VPT mention

<< Previous

Bullboard Posts

Next >>

Post by Jennifer2020on Mar 02, 2022 11:40pm

172 Views

Post# 34477731

GEHC has not objected to VPT mention

GE has recently announced they will now actually create a new seperate symbol for GEHC and other assets. George, VPT CEO is patiently waiting for final launch and this has led to some confusion. GEHC Edison program inclusion of Ventripoint still stands and can be confirmed by latest Management and Discussion on SEDAR OR recent updates to "investor deck" on VPT site.
-I hope this clears up some of the confusion

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects